Processing

Please wait...

Settings

Settings

Goto Application

1. WO2020223707 - ZINC PICOLINATE, MAGNESIUM PICOLINATE AND SELENIUM METHIONINE COMPOSITIONS AND METHODS OF USE

Publication Number WO/2020/223707
Publication Date 05.11.2020
International Application No. PCT/US2020/031191
International Filing Date 01.05.2020
IPC
A61K 31/4402 2006.01
AHUMAN NECESSITIES
61MEDICAL OR VETERINARY SCIENCE; HYGIENE
KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
31Medicinal preparations containing organic active ingredients
33Heterocyclic compounds
395having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
435having six-membered rings with one nitrogen as the only ring hetero atom
44Non-condensed pyridines; Hydrogenated derivatives thereof
4402only substituted in position 2, e.g. pheniramine, bisacodyl
A61P 15/10 2006.01
AHUMAN NECESSITIES
61MEDICAL OR VETERINARY SCIENCE; HYGIENE
PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
15Drugs for genital or sexual disorders; Contraceptives
10for impotence
A61P 39/06 2006.01
AHUMAN NECESSITIES
61MEDICAL OR VETERINARY SCIENCE; HYGIENE
PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
39General protective or antinoxious agents
06Free radical scavengers or antioxidants
CPC
A61K 31/198
AHUMAN NECESSITIES
61MEDICAL OR VETERINARY SCIENCE; HYGIENE
KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
31Medicinal preparations containing organic active ingredients
185Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic, hydroximic acids
19Carboxylic acids, e.g. valproic acid
195having an amino group
197the amino and the carboxyl groups being attached to the same acyclic carbon chain, e.g. gamma-aminobutyric acid [GABA], beta-alanine, epsilon-aminocaproic acid, pantothenic acid
198Alpha-aminoacids, e.g. alanine, edetic acids [EDTA],
A61K 31/4402
AHUMAN NECESSITIES
61MEDICAL OR VETERINARY SCIENCE; HYGIENE
KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
31Medicinal preparations containing organic active ingredients
33Heterocyclic compounds
395having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
435having six-membered rings with one nitrogen as the only ring hetero atom
44Non condensed pyridines; Hydrogenated derivatives thereof
4402only substituted in position 2, e.g. pheniramine, bisacodyl
A61K 33/04
AHUMAN NECESSITIES
61MEDICAL OR VETERINARY SCIENCE; HYGIENE
KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
33Medicinal preparations containing inorganic active ingredients
04Sulfur, selenium or tellurium; Compounds thereof
A61K 33/06
AHUMAN NECESSITIES
61MEDICAL OR VETERINARY SCIENCE; HYGIENE
KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
33Medicinal preparations containing inorganic active ingredients
06Aluminium, calcium or magnesium; Compounds thereof ; , e.g. clay
A61K 33/30
AHUMAN NECESSITIES
61MEDICAL OR VETERINARY SCIENCE; HYGIENE
KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
33Medicinal preparations containing inorganic active ingredients
24Heavy metals; Compounds thereof
30Zinc; Compounds thereof
A61P 15/10
AHUMAN NECESSITIES
61MEDICAL OR VETERINARY SCIENCE; HYGIENE
PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
15Drugs for genital or sexual disorders
10for impotence
Applicants
  • NUTRITION 21, LLC [US]/[US]
Inventors
  • KOMOROWSKI, James R.
  • OJALVO, Sara Perez
  • SYLLA, Sarah
Agents
  • CHISM, B. Dell
  • CHAMBERS, Scott
Priority Data
62/841,33601.05.2019US
Publication Language English (EN)
Filing Language English (EN)
Designated States
Title
(EN) ZINC PICOLINATE, MAGNESIUM PICOLINATE AND SELENIUM METHIONINE COMPOSITIONS AND METHODS OF USE
(FR) COMPOSITIONS DE PICOLINATE DE ZINC, DE PICOLINATE DE MAGNÉSIUM ET DE SÉLÉNOMÉTHIONINE ET MÉTHODES D'UTILISATION
Abstract
(EN)
The present application relates to zinc picolinate, magnesium picolinate and selenium methionine compositions and methods of use. The methods and compositions disclosed herein are particularly useful for optimizing antioxidant and hormone levels and improving bone mineral density.
(FR)
La présente invention concerne des compositions de picolinate de zinc, de picolinate de magnésium et de sélénométhionine et des méthodes d'utilisation. Les méthodes et les compositions décrites dans la description de la présente invention sont particulièrement utiles pour optimiser les taux d'antioxydants et d'hormones et améliorer la densité minérale osseuse.
Latest bibliographic data on file with the International Bureau